Thalidomide and celecoxib as potential modulators of irinotecan's activity in cancer patients Article

Villalona-Calero, Miguel, Schaaf, Larry, Phillips, Gary et al. (2007). Thalidomide and celecoxib as potential modulators of irinotecan's activity in cancer patients . CANCER CHEMOTHERAPY AND PHARMACOLOGY, 59(1), 23-33. 10.1007/s00280-006-0249-y

cited authors

  • Villalona-Calero, Miguel; Schaaf, Larry; Phillips, Gary; Otterson, Gregory; Panico, Kevin; Duan, Wenrui; Kleiber, Barbara; Shah, Manisha; Young, Donn; Wu, Wan-Hong; Kuhn, John

sustainable development goals

authors

publication date

  • January 1, 2007

webpage

published in

keywords

  • ACTIVATION
  • APOPTOSIS
  • CLINICAL PHARMACOKINETICS
  • CPT-11
  • INDUCIBLE CHEMORESISTANCE
  • INHIBITION
  • Life Sciences & Biomedicine
  • METASTATIC COLORECTAL-CANCER
  • NF-KAPPA-B
  • Oncology
  • Pharmacology & Pharmacy
  • Science & Technology
  • THERAPY
  • TRIAL

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 23

end page

  • 33

volume

  • 59

issue

  • 1